Coexistence of passive and carrier-mediated processes in drug transport
By K. Sugano, M. Kansy, Per Artursson, A. Avdeef, Stefanie Bendels, Li Di, Gerhard F. Ecker, B. Faller, H. Fischer, Grégori Gerebtzoff and 2 more. Nature reviews. Drug discovery, 2010
610 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/bd19e4231b5c7500acfd328473a3c90ccbe947c0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
In Pediatrics, Perinatology and Child Health
Citations in the corpus
- Pharmacokinetic aspects of retinal drug delivery. (2017, neutral): “Furthermore, it is important to note that the importance of transporter activity is relative and dependent on the rate of passive drug diffusion (Sugano et al., 2010).”
- Exosomes in Cancer Development, Metastasis and Drug Resistance: A Comprehensive Review (2013, neutral): “The advancements in high-resolution imaging have revealed that in addition to the well-recognized active [3] and passive transport systems [4], there exists a number of additional transport mechanisms through which cells communicate with the outside environment (within its microenvironment and even ”
- Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins (2015, methodology): “Artificial lipid bilayers [16] of various compositions or cell monolayers (typically the colorectal Caco-2 or renal MDCK cell lines) are widely used as model barriers [17].”